Found: 60
Select item for more details and to access through your institution.
The efficacy and safety of anamorelin among patients with diabetes.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1115, doi. 10.1007/s10147-024-02546-8
- By:
- Publication type:
- Article
Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 21, p. 1665, doi. 10.1111/1759-7714.15382
- By:
- Publication type:
- Article
Thoracic lymphangitis as an immune-related adverse event: a case report.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03123-5
- By:
- Publication type:
- Article
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58327-w
- By:
- Publication type:
- Article
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 6, p. 477, doi. 10.1111/1759-7714.15218
- By:
- Publication type:
- Article
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 96, doi. 10.1007/s10147-023-02451-6
- By:
- Publication type:
- Article
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 35, p. 3475, doi. 10.1111/1759-7714.15140
- By:
- Publication type:
- Article
Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight.
- Published in:
- Cancer Science, 2023, v. 114, n. 5, p. 2087, doi. 10.1111/cas.15736
- By:
- Publication type:
- Article
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 2, p. 356, doi. 10.1007/s10637-023-01353-8
- By:
- Publication type:
- Article
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 2, p. 435, doi. 10.1007/s11060-023-04300-y
- By:
- Publication type:
- Article
Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 9, p. 805, doi. 10.1111/1759-7714.14811
- By:
- Publication type:
- Article
Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1451, doi. 10.1002/cam4.5035
- By:
- Publication type:
- Article
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2455, doi. 10.1007/s00432-021-03784-3
- By:
- Publication type:
- Article
Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 14, p. 2064, doi. 10.1111/1759-7714.14529
- By:
- Publication type:
- Article
Laser-Assisted Melt Electrospinning of Poly(L-lactide-co-ε-caprolactone): Analyses on Processing Behavior and Characteristics of Prepared Fibers.
- Published in:
- Polymers (20734360), 2022, v. 14, n. 12, p. 2511, doi. 10.3390/polym14122511
- By:
- Publication type:
- Article
Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1496, doi. 10.1111/1759-7714.14421
- By:
- Publication type:
- Article
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 403, doi. 10.1007/s10637-021-01191-6
- By:
- Publication type:
- Article
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 411, doi. 10.1007/s10637-021-01183-6
- By:
- Publication type:
- Article
Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Everolimus-Eluting Stent-induced Pneumonitis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1633, doi. 10.1007/s00520-021-06572-4
- By:
- Publication type:
- Article
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1716, doi. 10.1007/s10637-021-01136-z
- By:
- Publication type:
- Article
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1732, doi. 10.1007/s10637-021-01140-3
- By:
- Publication type:
- Article
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1736, doi. 10.1093/jjco/hyab158
- By:
- Publication type:
- Article
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7503, doi. 10.1002/cam4.4268
- By:
- Publication type:
- Article
Bamboo Charcoal/Poly(L-lactide) Fiber Webs Prepared Using Laser-Heated Melt Electrospinning.
- Published in:
- Polymers (20734360), 2021, v. 13, n. 16, p. 2776, doi. 10.3390/polym13162776
- By:
- Publication type:
- Article
Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 7, p. 3961, doi. 10.1007/s00520-020-05953-5
- By:
- Publication type:
- Article
Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
BLUS1 kinase signal and a decrease in intercellular CO2 concentration are necessary for stomatal opening in response to blue light.
- Published in:
- Plant Cell, 2021, v. 33, n. 5, p. 1813, doi. 10.1093/plcell/koab067
- By:
- Publication type:
- Article
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 659, doi. 10.1007/s10147-020-01856-x
- By:
- Publication type:
- Article
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 571, doi. 10.1007/s10637-020-01005-1
- By:
- Publication type:
- Article
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Fatigue behavior and relation between fatigue resistance and tensile properties of poly(para‐phenylene‐co‐3,4'‐oxydiphenylene terephthalamide) fiber.
- Published in:
- Journal of Applied Polymer Science, 2021, v. 138, n. 5, p. 1, doi. 10.1002/app.49771
- By:
- Publication type:
- Article
Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 247, doi. 10.1002/cam4.3631
- By:
- Publication type:
- Article
Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 359, doi. 10.1111/cas.14707
- By:
- Publication type:
- Article
Structure and Properties of Poly(ethylene terephthalate) Fiber Webs Prepared via Laser-Electrospinning and Subsequent Annealing Processes.
- Published in:
- Materials (1996-1944), 2020, v. 13, n. 24, p. 5783, doi. 10.3390/ma13245783
- By:
- Publication type:
- Article
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1612, doi. 10.1007/s10637-020-00917-2
- By:
- Publication type:
- Article
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characterization of tumour mutation burden in patients with non‐small cell lung cancer and interstitial lung disease.
- Published in:
- Respirology, 2020, v. 25, n. 8, p. 850, doi. 10.1111/resp.13726
- By:
- Publication type:
- Article
Efficacy and tolerance of immune checkpoint inhibitors for non‐small cell lung cancer patients with interstitial lung disease – Reply.
- Published in:
- Respirology, 2020, v. 25, n. 8, p. 892, doi. 10.1111/resp.13785
- By:
- Publication type:
- Article
PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 5, p. 617, doi. 10.1093/jjco/hyaa033
- By:
- Publication type:
- Article
Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 194, doi. 10.1007/s10637-019-00808-1
- By:
- Publication type:
- Article
Acquired immunodeficiency associated with thymoma: a case report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The strategic effect of retailers' in‐store advertising services under product variety competition.
- Published in:
- Managerial & Decision Economics, 2019, v. 40, n. 3, p. 232, doi. 10.1002/mde.2994
- By:
- Publication type:
- Article
Leptomeningeal recurrence after long-term alectinib therapy for non-small cell lung cancer harboring an EML4-ALK fusion protein.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 184, doi. 10.1007/s10637-018-0633-6
- By:
- Publication type:
- Article
Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1052, doi. 10.1007/s10147-018-1305-4
- By:
- Publication type:
- Article
Rhodium‐Catalyzed Synthesis of Dialkyl(Heteroaryl)Phosphine Sulfides by Phosphinylation of Heteroaryl Sulfides.
- Published in:
- Advanced Synthesis & Catalysis, 2018, v. 360, n. 18, p. 3488, doi. 10.1002/adsc.201800630
- By:
- Publication type:
- Article
Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 9, p. 822, doi. 10.1093/jjco/hyy107
- By:
- Publication type:
- Article
Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
- Published in:
- Respirology, 2017, v. 22, n. 7, p. 1379, doi. 10.1111/resp.13075
- By:
- Publication type:
- Article